Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer

This publication has 21 references indexed in Scilit:

• Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy
  The Annals of Thoracic Surgery, 2003
• Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer
  Lung Cancer, 2002
• Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
  The Annals of Thoracic Surgery, 2002
• An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
  The Annals of Thoracic Surgery, 2002
• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
  American Journal of Roentgenology, 1997
• Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
  The Annals of Thoracic Surgery, 1993